Zhang H, Mao C, Li J, Huang Z, Gu X, Shen X, Ding H
(2019).
Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model.
Huang Z, Xia X, Mao C, Gu X, Shen X, Yang H, Ding H
(2020).
Pharmacokinetic-pharmacodynamic integration and resistance of tiamulin against Mycoplasma hyopneumoniae in an in vitro dynamic model.
Huang Z, Mao C, Wei Y, Gu X, Cai Q, Shen X, Ding H
(2020).
Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin.
de Jong A, Youala M, Klein U, El Garch F, Moyaert H, Simjee S, Maes D, Gyuranecz M, Pridmore A, Thomson JR, Ayling RD
(2020).
Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015-2016.